Implication of foam sclerosant inactivation by human whole blood in a laboratory setting
暂无分享,去创建一个
M. Whiteley | Alexis Gkantiragas | E. Dabbs | J. L. Nemchand | S. D. Dos Santos | Alina A Sheikh | M. Watkins | I. Shiangoli | L. Mainsiouw
[1] K. Parsi,et al. Detergent Sclerosants Stimulate Leukocyte Apoptosis and Oncosis. , 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[2] M. Whiteley,et al. Media Damage Following Detergent Sclerotherapy Appears to be Secondary to the Induction of Inflammation and Apoptosis: An Immunohistochemical Study Elucidating Previous Histological Observations. , 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[3] M. Whiteley,et al. The effects of environmental and compositional manipulations on the longevity of Tessari-made foam for sclerotherapy. , 2015, Journal of vascular surgery. Venous and lymphatic disorders.
[4] K. Parsi. Interaction of detergent sclerosants with cell membranes , 2015, Phlebology.
[5] K. Parsi,et al. Detergent sclerosants are deactivated and consumed by circulating blood cells. , 2015, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[6] J. Kovačević. [European guidelines for sclerotherapy in chronic venous disorders]. , 2014, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.
[7] R. Fanelli,et al. Timing and modality of the sclerosing agents binding to the human proteins: laboratory analysis and clinical evidences , 2014 .
[8] M. Watkins. Deactivation of sodium tetradecyl sulphate injection by blood proteins. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[9] J. Low,et al. In vitro effects of detergent sclerosants on antithrombotic mechanisms. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[10] E. Mariman,et al. Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomics , 2009, Genes & Nutrition.
[11] R. Armisén,et al. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results. , 2008, Journal of vascular surgery.
[12] K. Parsi,et al. The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro. , 2008, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[13] K. Parsi,et al. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[14] A. Cavezzi,et al. Preliminary Experience with a New Sclerosing Foam in the Treatment of Varicose Veins , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[15] M. N. Jones. A theoretical approach to the binding of amphipathic molecules to globular proteins. , 1975, The Biochemical journal.
[16] King Ww. Diagnosis and management of varicose veins , 1955 .
[17] L. Reiner. The Activity of Anionic Surface Active Compounds in Producing Vascular Obliteration , 1946, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[18] D. Jolley,et al. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[19] W. King. Diagnosis and management of varicose veins. , 1955, The Journal of the American Osteopathic Association.